Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Lina OlssonGudrun LindmarkMarie-Louise HammarströmSten HammarströmBasel SitohyPublished in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2020)
Although migration inhibitory factor 1 mRNA expression levels were related to severity of disease and lymph node analysis revealed that colon cancer patients with high levels had a shorter survival time after surgery than those with low levels, the difference was small and probably not useful in clinical practice.